| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000228629.2 |
AKT inhibitor VIII |
Brain lower grade glioma |
0.001996659 |
Resistant |
| ENSG00000228629.2 |
AKT inhibitor VIII |
Lung squamous cell carcinoma |
0.028365774 |
Resistant |
| ENSG00000228629.2 |
AKT inhibitor VIII |
Chronic Lymphocytic Leukemia |
0.044383898 |
Sensitive |
| ENSG00000228629.2 |
AKT inhibitor VIII |
Sarcoma |
0.04222375 |
Sensitive |
